CDC changes recommendations due to severe nirsevimab shortage during the 2023-2024 RSV season
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:59 |
|---|---|
| Enthalten in: |
Pediatric pulmonology - 59(2024), 4 vom: 18. März, Seite 1108-1109 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Rahmat, Zainab Syyeda [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Antibodies, Monoclonal, Humanized |
|---|
| Anmerkungen: |
Date Completed 29.03.2024 Date Revised 29.03.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1002/ppul.26841 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM367308568 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM367308568 | ||
| 003 | DE-627 | ||
| 005 | 20240330000810.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240119s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/ppul.26841 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1355.xml |
| 035 | |a (DE-627)NLM367308568 | ||
| 035 | |a (NLM)38240360 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Rahmat, Zainab Syyeda |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a CDC changes recommendations due to severe nirsevimab shortage during the 2023-2024 RSV season |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 29.03.2024 | ||
| 500 | |a Date Revised 29.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a RSV | |
| 650 | 4 | |a infectious diseases | |
| 650 | 4 | |a pediatric pulmonology | |
| 650 | 4 | |a pediatrics | |
| 650 | 4 | |a pulmonology | |
| 650 | 7 | |a nirsevimab |2 NLM | |
| 650 | 7 | |a VRN8S9CW5V |2 NLM | |
| 650 | 7 | |a Antibodies, Monoclonal, Humanized |2 NLM | |
| 650 | 7 | |a Palivizumab |2 NLM | |
| 650 | 7 | |a DQ448MW7KS |2 NLM | |
| 650 | 7 | |a Antiviral Agents |2 NLM | |
| 700 | 1 | |a Ahmad, Shkaib |e verfasserin |4 aut | |
| 700 | 1 | |a Malikzai, Abdullah |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Pediatric pulmonology |d 1993 |g 59(2024), 4 vom: 18. März, Seite 1108-1109 |w (DE-627)NLM012888230 |x 1099-0496 |7 nnns |
| 773 | 1 | 8 | |g volume:59 |g year:2024 |g number:4 |g day:18 |g month:03 |g pages:1108-1109 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1002/ppul.26841 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 59 |j 2024 |e 4 |b 18 |c 03 |h 1108-1109 | ||